AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rice, L. B.
Right arrow Articles by Gutmann, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rice, L. B.
Right arrow Articles by Gutmann, L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2004, p. 3028-3032, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.3028-3032.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Impact of Specific pbp5 Mutations on Expression of ß-Lactam Resistance in Enterococcus faecium

Louis B. Rice,1,2* Samuel Bellais,3 Lenore L. Carias,2 Rebecca Hutton-Thomas,1 Robert A. Bonomo,1,2 Patrick Caspers,4 Malcolm G. P. Page,4 and Laurent Gutmann3

Medical and Research Services, Louis Stokes Cleveland VA Medical Center,1 Case Western Reserve University, Cleveland, Ohio,2 LRMA, INSERM E0004, Université Paris VI, 75270 Paris Cedex 06, France,3 Basilea Pharmaceutica, CH-4005 Basel, Switzerland4

Received 28 January 2004/ Returned for modification 14 March 2004/ Accepted 8 April 2004

We tested the impact of individual PBP 5 mutations on expression of ampicillin resistance in Enterococcus faecium using a shuttle plasmid designed to facilitate expression of cloned pbp5 in ampicillin-susceptible E. faecium D344SRF. Substitutions that had been implicated in contributing to the resistance of clinical strains conferred only modest levels of resistance when they were present as single point mutations. The levels of resistance were amplified when some mutations were present in combination. In particular, a methionine-to-alanine change at position 485 (in close proximity to the active site) combined with the insertion of a serine at position 466 (located in a loop that forms the outer edge of the active site) was associated with the highest levels of resistance to all ß-lactams. Affinity for penicillin generally correlated with ß-lactam MICs for the mutants, but these associations were not strictly proportional.


* Corresponding author. Mailing address: Medical Service 111(W), Louis Stokes Cleveland VA Medical Center, 10701 East Blvd., Cleveland, OH 44106. Phone: (216) 791-3800, ext. 4800. Fax: (216) 231-3289. E-mail: louis.rice{at}med.va.gov.


Antimicrobial Agents and Chemotherapy, August 2004, p. 3028-3032, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.3028-3032.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.